Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity

Cancer Immunol Res (2024) 12 (11): 1525–1541.

https://doi.org/10.1158/2326-6066.CIR-24-0463

Published: 04 November 2024

View articletitled, Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity

Includes: Supplementary data

Journal Articles

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Cancer Immunol Res (2022) 10 (8): 996–1012.

https://doi.org/10.1158/2326-6066.CIR-21-0870

Published: 03 August 2022

View articletitled, Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Includes: Supplementary data

Journal Articles

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Xia Bu, Vikram R. Juneja, Carol G. Reynolds, Kathleen M. Mahoney, Melissa T. Bu, Kathleen A. McGuire, Seth Maleri, Ping Hua, Baogong Zhu, Sarah R. Klein, Edward A. Greenfield, Philippe Armand, Jerome Ritz, Arlene H. Sharpe, Gordon J. Freeman

Cancer Immunol Res (2021) 9 (12): 1465–1475.

https://doi.org/10.1158/2326-6066.CIR-21-0493

Published: 01 December 2021

View articletitled, Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Journal Articles

Abstract PO016: Single-cell analyses characterize circulating anti-tumor CD8 T cells and identify markers for their isolation

Cancer Immunol Res (2021) 9 (2_Supplement): PO016.

https://doi.org/10.1158/2326-6074.TUMIMM20-PO016

Published: 03 February 2021

View articletitled, Abstract PO016: Single-cell analyses characterize circulating anti-tumor CD8 T cells and identify markers for their isolation

Journal Articles

Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8⁺ T Cells

Jefte M. Drijvers, Jacob E. Gillis, Tara Muijlwijk, Thao H. Nguyen, Emily F. Gaudiano, Isaac S. Harris, Martin W. LaFleur, Alison E. Ringel, Cong-Hui Yao, Kiran Kurmi, Vikram R. Juneja, Justin D. Trombley, Marcia C. Haigis, Arlene H. Sharpe

Cancer Immunol Res (2021) 9 (2): 184–199.

https://doi.org/10.1158/2326-6066.CIR-20-0384

Published: 03 February 2021

View articletitled, Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells

Includes: Supplementary data

Journal Articles

Abstract IA16: Discovery of new immunotherapy targets and mechanisms leveraging CRISPR

Arlene H. Sharpe

Cancer Immunol Res (2021) 9 (2_Supplement): IA16.

https://doi.org/10.1158/2326-6074.TUMIMM20-IA16

Published: 03 February 2021

View articletitled, Abstract IA16: Discovery of new immunotherapy targets and mechanisms leveraging CRISPR

Journal Articles

Abstract PR6: Disrupting enhancers within the core epigenetic program of exhaustion improves T-cell responses and enhances tumor control

Debattama R. Sen, Sarah A. Weiss, Brian C. Miller, Pierre Tonnerre, Rose Al Abosy, Kathleen B. Yates, Kevin Bi, Martin W. Lafleur, David Wolski, Lauer Georg, Arlene H. Sharpe, W. Nicholas Haining

Cancer Immunol Res (2020) 8 (3_Supplement): PR6.

https://doi.org/10.1158/2326-6074.TUMIMM19-PR6

Published: 02 March 2020

View articletitled, Abstract PR6: Disrupting enhancers within the core epigenetic program of exhaustion improves T-cell responses and enhances tumor control

Journal Articles

Abstract A83: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller, Debattama R. Sen, Rose Al Abosy, Kevin Bi, Yamini Virkud, Martin W. LaFleur, Kathleen B. Yates, Ana Lako, Kristen Felt, Girish S. Naik, Michael Manos, Evisa Gjini, Jeffrey J. Ishizuka, F. Stephen Hodi, Scott J. Rodig, Arlene H. Sharpe, W. Nicholas Haining

Cancer Immunol Res (2020) 8 (3_Supplement): A83.

https://doi.org/10.1158/2326-6074.TUMIMM19-A83

Published: 02 March 2020

View articletitled, Abstract A83: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Journal Articles

Abstract PR9: Loss of PD-1 promotes antitumor immunity by improving functions of both PD-1+ and PD-1- CD8+ T cells in the tumor microenvironment

Kristen E. Pauken, Vikram R. Juneja, Alison Ringel, Jared H. Rowe, Kelly P. Burke, Peter T. Sage, Martin W. LaFleur, Juhi R. Kuchroo, Noga Ron-Harel, Seth Maleri, Jaclyn M. Long, Gordon J. Freeman, Nicolas Chevrier, Marcia C. Haigis, Arlene H. Sharpe

Cancer Immunol Res (2020) 8 (3_Supplement): PR9.

https://doi.org/10.1158/2326-6074.TUMIMM19-PR9

Published: 02 March 2020

View articletitled, Abstract PR9: Loss of PD-1 promotes antitumor immunity by improving functions of both PD-1+ and PD-1- CD8+ T cells in the tumor microenvironment

Journal Articles

Abstract A216: Functionally specialized subsets of exhausted CD8+ T-cells mediate tumor control and response to checkpoint blockade

Debattama R. Sen, Brian C. Miller, Rose Al Abosy, Kevin Bi, Martin W. LaFleur, Kathleen B. Yates, Ana Lako, Kristen D. Felt, Girish S. Naik, Michael Manos, Evisa Gjini, Yamini V. Virkud, Stephen Hodi, Scott J. Rodig, Arlene H. Sharpe, W. Nicholas Haining

Cancer Immunol Res (2019) 7 (2_Supplement): A216.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A216

Published: 01 February 2019

View articletitled, Abstract A216: Functionally specialized subsets of exhausted CD8+ T-cells mediate tumor control and response to checkpoint blockade

Journal Articles

Abstract A19: PD-1 modulation promotes antitumor immunity by improving metabolic fitness of both PD-1+ and PD-1- CD8+ T cells in the tumor

Kristen E. Pauken, Vikram R. Juneja, Peter T. Sage, Martin W. LaFleur, Juhi R. Kuchroo, Alison Ringel, Noga Ron-Harel, Seth P. Maleri, Gordon J. Freeman, Nicolas Chevrier, Marcia C. Haigis, Arlene H. Sharpe

Cancer Immunol Res (2018) 6 (9_Supplement): A19.

https://doi.org/10.1158/2326-6074.TUMIMM17-A19

Published: 01 September 2018

View articletitled, Abstract A19: PD-1 modulation promotes antitumor immunity by improving metabolic fitness of both PD-1+ and PD-1- CD8+ T cells in the tumor

Journal Articles

Abstract PR11: Dissecting mechanisms of PD-1 blockade with single-cell RNA-sequencing

Brian C. Miller, Marc H. Wadsworth, 2nd, Kevin Bi, Travis K. Hughes, Arlene H. Sharpe, Alex K. Shalek, W. Nicholas Haining

Cancer Immunol Res (2017) 5 (3_Supplement): PR11.

https://doi.org/10.1158/2326-6074.TUMIMM16-PR11

Published: 28 February 2017

View articletitled, Abstract PR11: Dissecting mechanisms of PD-1 blockade with single-cell RNA-sequencing

Journal Articles

Abstract A097: Tumor PDL1 blocks CTL cytotoxicity

Kathleen A. McGuire, Vikram R. Juneja, Robert T. Manguso, Martin W. LaFleur, Natalie Collins, W. Nicholas Haining, Gordon J. Freeman, Arlene H. Sharpe

Cancer Immunol Res (2016) 4 (11_Supplement): A097.

https://doi.org/10.1158/2326-6066.IMM2016-A097

Published: 31 October 2016

View articletitled, Abstract A097: Tumor PDL1 blocks CTL cytotoxicity

Journal Articles

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Keith L. Ligon, Scott J. Rodig, Shakti H. Ramkissoon, Kristen L. Jones, Amy Saur Conway, Xiaoyun Liao, Jun Zhou, Patrick Y. Wen, Annick D. Van Den Abbeele, F. Stephen Hodi, Lei Qin, Nancy E. Kohl, Arlene H. Sharpe, Glenn Dranoff, Gordon J. Freeman

Cancer Immunol Res (2016) 4 (2): 124–135.

https://doi.org/10.1158/2326-6066.CIR-15-0151

Published: 01 February 2016

View articletitled, Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Includes: Supplementary data

Journal Articles

Abstract IA02: Biology of the PD-1 pathway

Arlene H. Sharpe

Cancer Immunol Res (2016) 4 (1_Supplement): IA02.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-IA02

Published: 03 January 2016

View articletitled, Abstract IA02: Biology of the PD-1 pathway

Journal Articles

PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells

Kathleen M. Mahoney, Heather Sun, Xiaoyun Liao, Ping Hua, Marcella Callea, Edward A. Greenfield, F. Stephen Hodi, Arlene H. Sharpe, Sabina Signoretti, Scott J. Rodig, Gordon J. Freeman

Cancer Immunol Res (2015) 3 (12): 1308–1315.

https://doi.org/10.1158/2326-6066.CIR-15-0116

Published: 06 December 2015

View articletitled, PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells

Includes: Supplementary data

Journal Articles

Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade

Zachary A. Cooper, Vikram R. Juneja, Peter T. Sage, Dennie T. Frederick, Adriano Piris, Devarati Mitra, Jennifer A. Lo, F. Stephen Hodi, Gordon J. Freeman, Marcus W. Bosenberg, Martin McMahon, Keith T. Flaherty, David E. Fisher, Arlene H. Sharpe, Jennifer A. Wargo

Cancer Immunol Res (2014) 2 (7): 643–654.

https://doi.org/10.1158/2326-6066.CIR-13-0215

Published: 01 July 2014

View articletitled, Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Abstract PO016: Single-cell analyses characterize circulating anti-tumor CD8 T cells and identify markers for their isolation

Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8⁺ T Cells

Abstract IA16: Discovery of new immunotherapy targets and mechanisms leveraging CRISPR

Abstract PR6: Disrupting enhancers within the core epigenetic program of exhaustion improves T-cell responses and enhances tumor control

Abstract A83: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Abstract PR9: Loss of PD-1 promotes antitumor immunity by improving functions of both PD-1+ and PD-1- CD8+ T cells in the tumor microenvironment

Abstract A216: Functionally specialized subsets of exhausted CD8+ T-cells mediate tumor control and response to checkpoint blockade

Abstract A19: PD-1 modulation promotes antitumor immunity by improving metabolic fitness of both PD-1+ and PD-1- CD8+ T cells in the tumor

Abstract PR11: Dissecting mechanisms of PD-1 blockade with single-cell RNA-sequencing

Abstract A097: Tumor PDL1 blocks CTL cytotoxicity

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

Abstract IA02: Biology of the PD-1 pathway

PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells

Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only